MedTrace Logo

Thiol Disulfide Balance in Cervix Cancer

NCT04258553 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 123

Last updated 2020-04-30

No results posted yet for this study

Summary

The aim of this research is to evaluate thiol-disulfide balance in cervix cancer patients

Conditions

  • Cervix Cancer
  • Oxidative Stress

Interventions

DIAGNOSTIC_TEST

Disulphide(μmol/L)

Aforementioned oxidative stress markers will be measured via Cobas c501(Roche Diagnostics, Indianapolis, IN, USA) used with spectrophotometry

DIAGNOSTIC_TEST

Total Oxidant Capacity(μmolH2O2Equiv/L)

Aforementioned oxidative stress markers will be measured via Cobas c501(Roche Diagnostics, Indianapolis, IN, USA) used with spectrophotometry

DIAGNOSTIC_TEST

Ischemia Modified Albumin(IU/mL)

The serum Ischemia Modified Albumin concentrations were measured as described by Bar-Or et al. (Bar-Or et al. 2000).

Sponsors & Collaborators

  • Muğla Sıtkı Koçman University

    lead OTHER

Principal Investigators

  • Burak Sezgin, MD · Mugla Sıtkı Kocman University Faculty of Medicine

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-09-01
Primary Completion
2020-01-20
Completion
2020-02-04

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04258553 on ClinicalTrials.gov